Appendix, Gallbladder and Surgical Emergencies23 Sep 2024
The application of indocyanine green (ICG) fluorescence imaging in laparoscopic bile duct exploration markedly enhanced surgical efficiency. Patients receiving ICG exhibited faster identification of biliary structures, reduced operative time, and shorter postoperative hospital stays compared to those using conventional fiber-optic imaging. Additionally, the ICG group…
Int J Surg21 Sep 2024
Integrating the cystic plate approach with ICG fluorescence significantly enhances laparoscopic anatomical hepatectomy. In a study of 38 patients, this technique demonstrated no increase in operation time or intraoperative blood loss compared to conventional methods. Postoperative liver function and recovery metrics were also unaffected, confirming…
Eur Surg Res21 Sep 2024
A systematic review of 22 studies involving 4,043 patients revealed that enhanced recovery after surgery (ERAS) significantly reduced overall complications (relative risk: 0.83) and specifically Clavien-Dindo grade 1 and 2 complications. ERAS also led to a shorter time to chemotherapy. Importantly, ERAS demonstrated no increase…
Ann Surg20 Sep 2024
The revised IAP 2023 guidelines significantly improved diagnostic performance for predicting malignancy in patients with branch-duct or mixed-type intraductal papillary mucinous neoplasms (IPMN). Among 556 reviewed patients, the guidelines displayed higher specificity (29.1% vs. 4.9% for IAP 2017), a positive predictive value of 48.6%, and…
Ann Surg Oncol19 Sep 2024
A systematic review and meta-analysis involving 930 patients revealed that anatomic resection (AR) significantly enhances both overall survival (OS) and disease-free survival (DFS) compared to non-anatomic resection (non-AR) for resectable intrahepatic cholangiocarcinoma. The OS rates at 1, 3, and 5 years were 71.5%, 46.1%, and…
Eur J Surg Oncol18 Sep 2024
A study involving 1511 major hepatectomies found that preoperative future liver remnant (FLR) volume assessment significantly impacts posthepatectomy liver failure (PHLF) risk. High-risk patients with FLR
World J Surg Oncol18 Sep 2024
A multicenter study evaluated the ADV score's efficacy in identifying hepatocellular carcinoma (HCC) patients at high risk of recurrence. The analysis involved 755 patients and established risk groups based on microvascular invasion and Edmonson-Steiner grade. Results showed that the ADV score differentiates these groups effectively,…
World J Surg Oncol18 Sep 2024
A novel nomogram utilizing the number of positive lymph nodes has demonstrated effectiveness in predicting overall survival (OS) for patients with pancreatic head cancer following radical surgery. Analyzed data from over 3,200 patients identified key independent risk factors, including age, tumor extent, and chemotherapy. The…
J Surg Oncol17 Sep 2024
A single-center experience with hepatic artery infusion pump therapy for unresectable colorectal liver metastases showed successful placement in most patients, with a complication rate of 37.5%. The median overall survival (OS) from diagnosis was 55.2 months, though concurrent primary tumor resection led to inferior OS…
BMC Gastroenterol17 Sep 2024
A systematic review and meta-analysis compared endoscopic nasobiliary drainage (ENBD) and percutaneous transhepatic cholangial drainage (PTCD) in advanced hilar cholangiocarcinoma patients. Results indicated PTCD had a significantly higher success rate and was more effective in lowering total bilirubin levels post-drainage. While ENBD showed a lower…